Pelvic Floor Stimulation as a Treatment of Urinary and Fecal Incontinence
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs coverage of non-implantable pelvic floor electrical and magnetic stimulation as treatments for urinary and fecal incontinence for Blue Cross Blue Shield - Rhode Island members, with distinctions for Medicare Advantage and Commercial products.
No material clinical or coverage changes in this revision.
Coverage Criteria
Medicare Advantage — Covered Indication
Covered when ALL of the following are met:
Per Medicare Advantage requirements.
Failed trial defined as no clinically significant improvement in urinary continence after completing 4 weeks of an ordered PME plan.
Insufficient evidence / Not covered
Not covered / insufficient evidence in the following situations:
Systematic reviews and RCTs have not shown consistent benefit for fecal incontinence; evidence insufficient.
Medicare Advantage policy specifies magnetic stimulation for urinary incontinence is not covered.
Commercial Products — Not Covered
Commercial product contracts exclude the following:
Benefits may vary by group; refer to the member's Evidence of Coverage or subscriber agreement for benefit specifics. Services determined to be non-covered may result in nonpayment and potential member financial liability unless prior written agreement is obtained.
This policy addresses coverage for non-implantable pelvic floor stimulation (PFS) modalities — electrical stimulation delivered via vaginal or anal probes and extracorporeal magnetic stimulation — with different stances for Medicare Advantage and Commercial products. For Medicare Advantage members, non-implantable pelvic floor electrical stimulation is covered for the treatment of stress and/or urge urinary incontinence in cognitively intact patients who have failed a documented trial of pelvic muscle exercise (PME). In contrast, pelvic floor magnetic stimulation for urinary incontinence and any pelvic floor stimulation for fecal incontinence are not covered for Medicare Advantage due to insufficient evidence. For Commercial products, all non-implantable pelvic floor electrical or magnetic stimulation for urinary or fecal incontinence is not covered and considered a contract exclusion.
Services that are determined to be outside the policy’s covered indications — including all non-implantable pelvic floor electrical or magnetic stimulation for urinary and fecal incontinence under Commercial products and magnetic or fecal indications under Medicare Advantage — are treated as contract exclusions or non-covered benefits. If a service is determined to be not medically necessary or a non-covered benefit, it may result in denial of payment; providers should not bill the member for such services unless there is a prior written agreement in which the member consents to be financially responsible.
The evidence base comprises randomized controlled trials and systematic reviews. Systematic reviews of RCTs for electrical PFS in urinary incontinence have not consistently shown improvements in symptoms, disease status, quality of life, or other patient-centered outcomes compared with placebo or conservative treatments, and meta-analyses likewise do not demonstrate clear benefit in men after prostate surgery. For magnetic PFS in urinary incontinence, RCTs and a systematic review are limited by small trial numbers, short follow-up, methodological limitations, and heterogeneity, leading to an insufficient evidence conclusion. For fecal incontinence, RCTs and systematic reviews of electrical PFS have not shown superiority to control interventions, and there are no RCTs for magnetic PFS; overall the evidence is insufficient to determine meaningful health outcome benefits.
Coding
| 53899 | Unlisted procedure, urinary system |
| E0740 | Nonimplanted pelvic floor electrical stimulator, complete system |
| 53899 | Unlisted procedure, urinary system |
| E0740 | Nonimplanted pelvic floor electrical stimulator, complete system |
| 53899 | Unlisted procedure, urinary system |
Provider Actions & Requirements
Prior authorization: Not applicable
Prior authorization is not required for pelvic floor stimulation under this policy.
Check member-specific prior authorization and benefits
This policy describes coverage but does not list member-specific prior authorization processes or benefit limits; verify member benefits and any authorization requirements through the provider call center or payer systems before scheduling services.
- Contact the provider call center for member-specific benefits and prior authorization requirements.
- Member subscriber agreement or employer agreement determines actual benefits.
PME trial required (≥ 4 weeks) before MA electrical stimulation
For Medicare Advantage coverage of non-implantable pelvic floor electrical stimulation, a documented trial of pelvic muscle exercise (PME) training of at least 4 weeks with no clinically significant improvement is required prior to coverage.
- A failed PME trial is defined as no clinically significant improvement after completing 4 weeks of an ordered PME plan.
Additional provider actions: confirm and document MA coverage elements
Confirm and document all required elements for Medicare Advantage electrical stimulation coverage as outlined in the policy.
- Patient is cognitively intact.
- Documented failed trial of PME training (4 weeks) with no clinically significant improvement.
- Clinical indication: stress and/or urge urinary incontinence.
- Reference Medicare National Coverage Determination parameters when applicable.
Documentation required for MA electrical stimulation
When requesting Medicare Advantage coverage for non-implantable pelvic floor electrical stimulation, document the patient is cognitively intact and has failed a documented 4-week PME training plan with no clinically significant improvement; include the severity and type of urinary incontinence.
- Cognitive status (cognitively intact).
- Evidence of PME training: ordered plan, duration (4 weeks), and outcome (no clinically significant improvement).
- Clinical diagnosis specifying stress and/or urge urinary incontinence.
Benefits and eligibility: check member contract
Member contract, subscriber agreement, or employer agreement governs benefits and supersedes this policy; verify eligibility and benefit details with the member's plan documents or the provider call center.
- Benefits and eligibility determined by subscriber agreement or member certificate and/or employer agreement.
- Those documents supersede the provisions of this medical policy.
Commercial product exclusion — no coverage
For Commercial products, pelvic floor electrical or magnetic stimulation with a non-implantable stimulator for urinary and fecal incontinence is excluded from coverage and considered a contract exclusion; do not bill expecting coverage.
- Commercial product exclusion applies to both electrical and magnetic non-implantable pelvic floor stimulation.
- Benefits may vary by group; refer to Evidence of Coverage for group-specific details.
Medicare Advantage noncoverage: magnetic stimulation and fecal incontinence
Medicare Advantage does not cover pelvic floor magnetic stimulation for urinary incontinence, nor does it cover any pelvic floor stimulation for fecal incontinence; do not submit these services for MA coverage.
- Magnetic stimulation for stress/urge urinary incontinence is not covered (insufficient evidence).
- Any pelvic floor electrical or magnetic stimulation for fecal incontinence is not covered (insufficient evidence).
Financial liability if service non-covered — member billing rules
If services are determined to be not medically necessary or are non-covered benefits, the provider may not charge the member for the services unless the member has been informed in advance and agreed in writing to pay; verify authorization and obtain written member agreement if proceeding at member expense.
- Nonpayment may result when services are not medically necessary or are non-covered benefits.
- Provider may not charge the member unless prior written agreement is obtained.
Background
Pelvic floor stimulation refers to non-implantable modalities intended to activate or strengthen pelvic floor musculature. Electrical PFS is typically delivered via vaginal or anal probes connected to an external pulse generator to induce muscle contraction and potentially improve urethral closure. Magnetic PFS is delivered extracorporeally with the patient seated on a specialized chair that induces pelvic floor muscle activation without internal electrodes. Session frequency, stimulus parameters, electrode placement, and care setting (office, physical therapy, or home) vary across studies and devices.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.